These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11331851)

  • 1. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury.
    Söderström T; Hedner U; Arnljots B
    J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study.
    Lev EI; Marmur JD; Zdravkovic M; Osende JI; Robbins J; Delfin JA; Richard M; Erhardtsen E; Thomsen MS; Lincoff AM; Badimon JJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1036-41. PubMed ID: 12067917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local application of FFR-rFVIIa reduces thrombus formation at arterial anastomosis in rats.
    Sørensen HB; Kristensen AT; Ravn HB; Fuglsang J; Hjortdal VE
    Microsurgery; 1999; 19(8):369-73. PubMed ID: 10594911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa.
    Arnljots B; Ezban M; Hedner U
    J Vasc Surg; 1997 Feb; 25(2):341-6. PubMed ID: 9052569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig.
    Himber J; Refino CJ; Burcklen L; Roux S; Kirchhofer D
    Thromb Haemost; 2001 Mar; 85(3):475-81. PubMed ID: 11307818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model.
    Holst J; Kristensen AT; Kristensen HI; Ezban M; Hedner U
    Eur J Vasc Endovasc Surg; 1998 Jun; 15(6):515-20. PubMed ID: 9659887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-thrombotic and haemorrhagic effects of active site-inhibited factor VIIa in rats.
    Ghrib F; Léger P; Ezban M; Kristensen A; Cambus J; Boneu B
    Br J Haematol; 2001 Feb; 112(2):506-12. PubMed ID: 11167855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S; Johansson K; Kjaer M; Elg M
    Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
    Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rFVIIai in Acute Coronary Syndromes.
    Sorensen BB; Hedner U; Erhardtsen E
    Semin Vasc Med; 2003 May; 3(2):199-204. PubMed ID: 15199483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective tissue factor/factor VIIa Inhibitor, ER-410660, and its prodrug, E5539, have anti-venous and anti-arterial thrombotic effects with a low risk of bleeding.
    Nagakura T; Tabata K; Kira K; Hirota S; Clark R; Matsuura F; Hiyoshi H
    Thromb Res; 2013 Aug; 132(2):271-9. PubMed ID: 23827699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis.
    Parry TJ; Huang Z; Chen C; Connelly MA; Perzborn E; Andrade-Gordon P; Damiano BP
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):720-6. PubMed ID: 21986468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
    Malm K; Dahlbäck B; Arnljots B
    Plast Reconstr Surg; 2003 Apr; 111(5):1659-66. PubMed ID: 12655212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of potential antigenicity of active-site-inhibited recombinant human FVIIa (FFR-rFVIIa) in an immune-tolerant rat model.
    Nicolaisen EM; Kristensen H; Kristensen A; Hedner U
    Thromb Haemost; 2002 May; 87(5):836-9. PubMed ID: 12038786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
    Hedner U; Erhardtsen E
    Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis.
    Arnljots B; Söderström T; Ezban M; Hedner U
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S145-8. PubMed ID: 10850581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits.
    Fattorutto M; Tourreau-Pham S; Mazoyer E; Bonnin P; Raphaël M; Morin F; Cupa M; Samama CM
    Can J Anaesth; 2004; 51(7):672-9. PubMed ID: 15310634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
    Szalony JA; Suleymanov OD; Salyers AK; Panzer-Knodle SG; Blom JD; LaChance RM; Case BL; Parlow JJ; South MS; Wood RS; Nicholson NS
    Thromb Res; 2003; 112(3):167-74. PubMed ID: 14967414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.